Ozempic and Wegovy, made by Novo Nordisk, mimic the effects of GLP-1, a type of hormone in the body that impacts everything from the brain to muscle to the pancreas, stomach and liver, according to the National Institutes of Health
Key structural characteristics include: The peptide exhibits remarkable stability compared to many bioactive peptides, remaining active in gastric acid conditions and showing resistance to enzymatic degradation, making it suitable for diverse experimental applications
Nonetheless, the overlap between GLP-1 side effects and IBS symptoms means we need to look carefully at how these medications might exacerbate or alleviate IBS in different scenarios
Four capsules per day
Reading Time: 5 minutes | Weve accepted that avoidance and prevention are critical for not getting infected, but if you get COVID-19 and coronaviruses swarm your cells, are there ways to bend the curve